Beijing Konruns Pharmaceutical Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Public
- Established
- 2003-09-03
- Employees
- 447
- Market Cap
- -
- Website
- http://www.konruns.cn
Clinical Trials
12
Active:0
Completed:3
Trial Phases
4 Phases
Phase 1:4
Phase 2:4
Phase 3:2
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (33.3%)Phase 2
4 (33.3%)Not Applicable
2 (16.7%)Phase 3
2 (16.7%)A Study of KC1086 in Patients With Advanced Solid Tumors
- First Posted Date
- 2025-08-12
- Last Posted Date
- 2025-08-12
- Lead Sponsor
- Beijing Konruns Pharmaceutical Co., Ltd.
- Target Recruit Count
- 66
- Registration Number
- NCT07118709
A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma
- First Posted Date
- 2024-08-21
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Beijing Konruns Pharmaceutical Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT06564272
- Locations
- 🇨🇳
Beijing Children's Hospital Affiliated to Capital Medical University, Beijing, Beijing, China
A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer
Phase 3
Recruiting
- Conditions
- Esophageal Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2024-01-08
- Last Posted Date
- 2024-03-07
- Lead Sponsor
- Beijing Konruns Pharmaceutical Co., Ltd.
- Target Recruit Count
- 490
- Registration Number
- NCT06194734
- Locations
- 🇨🇳
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China
A Study of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease
- First Posted Date
- 2023-08-01
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- Beijing Konruns Pharmaceutical Co., Ltd.
- Target Recruit Count
- 414
- Registration Number
- NCT05970783
- Locations
- 🇨🇳
Beijing Hospital of Traditional Chinese Medicine affiliated to Capital Medical University, Beijing, Beijing, China
A Study of KC1036 in Patients with Advanced Thymic Tumors
- First Posted Date
- 2023-01-13
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- Beijing Konruns Pharmaceutical Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT05683886
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
🇨🇳West China Hospital, Chengdu, Sichuan, China
- Prev
- 1
- 2
- 3
- Next
News
No news found